Citation

Walker DP, Zawistoski MP, McGlynn MA, Li JC, Kung DW, Bonnette PC, Baumann A, Buckbinder L, Houser JA, Boer J, Mistry A, Han S, Xing L, Guzman-Perez A.: Sulfoximine-substituted trifluoromethylpyrimidine analogs as inhibitors of proline-rich tyrosine kinase 2 (PYK2) show reduced hERG activity. Bioorg Med Chem Lett, Volume 19 (12), 2009

Authors

Baumann A, Boer J, Bonnette PC, Buckbinder L, Guzman-Perez A., Han S, Houser JA, Kung DW, Li JC, McGlynn MA, Mistry A, Walker DP, Xing L, Zawistoski MP

Journal

Bioorg Med Chem Lett

Year

2009

DOI

10.1016/j.bmcl.2009.04.093

PubMed

19428251

Machine-readable

REST APIRDF